Digest Network Come funziona
Network
/
Società
Sa
Non verificato

Satellos BioScience Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

45 comunicati stampa

Guarda tutti i comunicati
09/12/2025
Attrezzature medico-sanitarie
Igiene alimentare
Salute
Medicina - Varie
Biotecnologia
Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
25/11/2025
Web e Social Network
Eventi
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Satellos to Participate in December Investor Conferences
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
18/11/2025
Industria
Salute
Biologia
Scienza
Farmaceutica
Biotecnologia
Satellos Announces Publication in Nature Communications Supporting its Novel Treatment Approach for Duchenne Muscular Dystrophy
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
14/11/2025
Mercato del lavoro
Mercato azionario
Salute
Biologia
Biotecnologia
Medicina - Varie
Farmaceutica
Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
30/10/2025
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Eventi
Satellos to Participate in November Investor Conferences
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
21/10/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
10/10/2025
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
Satellos Announces New Data Further Demonstrating Safety, Tolerability, and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
29/09/2025
Eventi
Industria
Scienza
Igiene alimentare
Medicina - Varie
Biologia
Biotecnologia
Salute
Farmaceutica
Satellos to Present SAT-3247 Phase 1 Clinical Data in Late-Breaking Poster Session at the 2025 World Muscle Society Congress
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
22/09/2025
Industria
Scienza
Biologia
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Satellos Announces IND Submission to the U.S. FDA and Global Regulatory Filings to Advance a Phase 2 Clinical Trial of SAT-3247 in Children with Duchenne Muscular Dystrophy
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0
21/08/2025
Web e Social Network
Eventi
Finanza
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Satellos to Participate in Four September Institutional and Retail Investor Conferences
Fonte
Satellos BioScience Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0